Completed PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT01248208

FluMist in Egg Allergic Patients (FluEMIST)

Flu Vaccine in Egg-allergic Patients Minimizing Injections Safety Trial

Sponsor: Scripps Clinic

Conditions Egg Allergy Eligible for Vaccination Against Influenza

Interventions FluMist intranasal influenza vaccine Intramuscular influenza injection (flu shot)

Updated 6 times since 2017 Last updated: Oct 1, 2018 Started: Sep 30, 2010 Primary completion: Sep 1, 2011 Completion: Oct 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Egg Allergy and Eligible for Vaccination Against Influenza, this trial is completed. The trial is conducted by Scripps Clinic and has accumulated 6 data snapshots since 2010. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1/PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Nov 2018 — Jan 2021 [monthly]

Completed PHASE1_PHASE2

Status: Unknown Status → Completed

▶ Show 1 earlier version

Jan 2017 — Nov 2018 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Sep 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Scripps Clinic
University of Michigan
University of South Alabama
University of Texas
Walter Reed Army Medical Center

Data source: Walter Reed Army Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Washington D.C., United States